Monday, March 31, 2025 | 09:09 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

World Coronavirus Dispatch: Moderna jab retains high efficacy after 6 mnths

Sweden tops Europe in new cases per person, J&J's vaccine pause is latest blow to Europe's inoculation, Japan scrambles to ensure safety as Olympics and other pandemic-related news across the globe

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

Moderna vaccine | File photo

Akash Podishetty Hyderabad
Johnson & Johnson’s vaccine pause: Latest blow to Europe’s inoculation

The United States regulator has called for a pause on Johnson and Johnson's single dose coronavirus vaccine, citing probe into rare blood-clotting cases. Following the announcement in pause, the J&J said it will delay the vaccine rollout in Europe as a precautionary measure and that it will communicate with regulators to ensure safe rollout in the future. The latest development comes as another blow to the Europe's sluggish and poor inoculation drive, that is already struggling with shortage of doses, the AstraZeneca setback, confusion in policies and logistical problems.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in